If you haven't sold HUMA before the previous earnings:

Then analyzing the options chain and the chart patterns of HUMA Humacyte prior to the earnings report this week,
I would consider purchasing the 5usd strike price Calls with
an expiration date of 2024-9-20,
for a premium of approximately $1.22.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.

Then analyzing the options chain and the chart patterns of HUMA Humacyte prior to the earnings report this week,
I would consider purchasing the 5usd strike price Calls with
an expiration date of 2024-9-20,
for a premium of approximately $1.22.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade chiuso: obiettivo raggiunto
HUMA traded at $7.02 after earnings, and the calls went up from $1.22 (when I wrote this article) to $2.50 at the close on friday (a lot higher during the week), for a decent 2X gain!Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
